Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

131 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Cross-reactive antibodies against gangliosides and Campylobacter jejuni lipopolysaccharides in patients with Guillain-Barré or Miller Fisher syndrome.
Jacobs BC, Hazenberg MP, van Doorn PA, Endtz HP, van der Meché FG. Jacobs BC, et al. Among authors: van doorn pa, van der meche fg. J Infect Dis. 1997 Mar;175(3):729-33. doi: 10.1093/infdis/175.3.729. J Infect Dis. 1997. PMID: 9041356
The effects of Guillain-Barré syndrome on the close relatives of patients during the first year.
Bernsen RA, de Jager AE, van der Meché FG, Suurmeijer TP. Bernsen RA, et al. Among authors: van der meche fg. J Neurol Sci. 2006 May 15;244(1-2):69-75. doi: 10.1016/j.jns.2006.01.002. Epub 2006 Feb 14. J Neurol Sci. 2006. PMID: 16476450
Psychosocial dysfunction in the first year after Guillain-Barré syndrome.
Bernsen RA, de Jager AE, Kuijer W, van der Meché FG, Suurmeijer TP. Bernsen RA, et al. Among authors: van der meche fg. Muscle Nerve. 2010 Apr;41(4):533-9. doi: 10.1002/mus.21536. Muscle Nerve. 2010. PMID: 19941334 Clinical Trial.
Psychometric evaluation of a new handicap scale in immune-mediated polyneuropathies.
Merkies IS, Schmitz PI, Van Der Meché FG, Samijn JP, Van Doorn PA. Merkies IS, et al. Among authors: van der meche fg, van doorn pa. Muscle Nerve. 2002 Mar;25(3):370-7. doi: 10.1002/mus.10045. Muscle Nerve. 2002. PMID: 11870713
Long-term impact on work and private life after Guillain-Barré syndrome.
Bernsen RA, de Jager AE, Schmitz PI, van der Meché FG. Bernsen RA, et al. Among authors: van der meche fg. J Neurol Sci. 2002 Sep 15;201(1-2):13-17. doi: 10.1016/s0022-510x(02)00158-2. J Neurol Sci. 2002. PMID: 12163188
Amantadine for treatment of fatigue in Guillain-Barre syndrome: a randomised, double blind, placebo controlled, crossover trial.
Garssen MP, Schmitz PI, Merkies IS, Jacobs BC, van der Meché FG, van Doorn PA. Garssen MP, et al. Among authors: van der meche fg. J Neurol Neurosurg Psychiatry. 2006 Jan;77(1):61-5. doi: 10.1136/jnnp.2004.046227. J Neurol Neurosurg Psychiatry. 2006. PMID: 16361594 Free PMC article. Clinical Trial.
Epstein-Barr virus and disease activity in multiple sclerosis.
Buljevac D, van Doornum GJ, Flach HZ, Groen J, Osterhaus AD, Hop W, van Doorn PA, van der Meché FG, Hintzen RQ. Buljevac D, et al. Among authors: van der meche fg. J Neurol Neurosurg Psychiatry. 2005 Oct;76(10):1377-81. doi: 10.1136/jnnp.2004.048504. J Neurol Neurosurg Psychiatry. 2005. PMID: 16170080 Free PMC article.
Cross-reactive anti-galactocerebroside antibodies and Mycoplasma pneumoniae infections in Guillain-Barré syndrome.
Ang CW, Tio-Gillen AP, Groen J, Herbrink P, Jacobs BC, Van Koningsveld R, Osterhaus AD, Van der Meché FG, van Doorn PA. Ang CW, et al. Among authors: van koningsveld r, van der meche fg, van doorn pa. J Neuroimmunol. 2002 Sep;130(1-2):179-83. doi: 10.1016/s0165-5728(02)00209-6. J Neuroimmunol. 2002. PMID: 12225900
Quality of life complements traditional outcome measures in immune-mediated polyneuropathies.
Merkies IS, Schmitz PI, van der Meché FG, Samijn JP, van Doorn PA; Inflammatory Neuropathy Cause and Treatment (INCAT) group. Merkies IS, et al. Among authors: van der meche fg, van doorn pa. Neurology. 2002 Jul 9;59(1):84-91. doi: 10.1212/wnl.59.1.84. Neurology. 2002. PMID: 12105312
Infections and course of disease in mild forms of Guillain-Barré syndrome.
Van Koningsveld R, Schmitz PI, Ang CW, Groen J, Osterhaus AD, Van der Meché FG, Van Doorn PA. Van Koningsveld R, et al. Among authors: van der meche fg, van doorn pa. Neurology. 2002 Feb 26;58(4):610-4. doi: 10.1212/wnl.58.4.610. Neurology. 2002. PMID: 11865140
131 results
Jump to page
Feedback